Noncanonical DNA virus sensing through IKK-alpha–driven interferon signaling
Official title: Noncanonical DNA Virus Sensing via an IKK-alpha-Driven Interferon Signaling Cascade
Funded at Western University of Health Sciences · NIH-11356021 · Data updated 2026-11-12
Researchers are exploring a new pathway by which the body detects DNA from viruses and triggers protective interferon responses, which could lead to better treatments for viral infections.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Western University of Health Sciences NIH-funded |
| Lab location | 1 site (Pomona, United States) |
| Project start | August 7, 2026 |
| Project end | July 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $200,600 |
| NIH project number | 1R21AI199683-01 |
| Project ID | NIH-11356021 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients affected by gammaherpesvirus infections (e.g., EBV, KSHV) or those with impaired canonical interferon pathways may benefit from future therapies arising from this work.
✕Less likely to help
The immediate study does not involve patient participation; benefits would be realized in future therapies after further development.
What this research studies
This project looks at how certain DNA viruses trigger an interferon response through a surprising, nontraditional route that uses IKK-alpha instead of the usual TBK1 pathway. Using knockout mouse cells, RNA sequencing, biochemical studies, and reporter tests, the team aims to map the upstream sensors and key transcription factors involved. The work could reveal new targets to boost antiviral defenses in a range of infections. By understanding this alternative signaling axis, scientists hope to inform future therapies that enhance immune responses where standard pathways are bypassed by viruses.
Why it matters
Potential benefit: Could identify new targets to strengthen antiviral responses in patients with gammaherpesvirus infections.
How similar studies have gone: Early data from related research suggest alternative interferon signaling paths can be engaged, but this specific IKK-alpha–driven axis is novel and exploratory.
Where this research is happening
-
Western University of Health Sciences
Pomona, United States Active
Researchers
- Principal investigator: Sanchez, David Jesse — Western University of Health Sciences
- Study coordinator: Sanchez, David Jesse
Related research
Other NIH-funded projects on the same topics.
-
HIV blocks immune alarm signals by targeting IPS-1 to weaken interferon responses
A study in people with HIV explores how the virus disrupts a key alarm system (interferon) by manipulating a molecule called IPS-1 to help the virus hide and replicate.
-
Cooperative Modulation of Piezo Channels and Heart Health
A study to understand how PIEZO channels in heart and blood vessels respond to mechanical forces and how their behavior might contribute to conditions like hypertension and cardiomyopathy.
-
Protein Kinase R and hantavirus organ targeting in humans
Researchers are studying how PKR and related proteins influence where hantaviruses attack in the body, which could lead to better protection against kidney and heart/lung damage in people exposed to these viruses.
-
Preventing UV-driven skin cancer with a skin-targeted form of R-carvedilol
A patient-friendly look at a cancer-prevention approach using a skin-targeted version of R-carvedilol to block UV-driven skin cancer without affecting heart health.
-
Pharmacological modulation of Piezo1 channels
A new NIH grant is exploring how to control Piezo1 ion channels with drugs to treat diseases linked to mechanical sensing in the body.
-
Understanding brain changes in Angelman syndrome
This work explores how certain proteins and tiny cell packages called extracellular vesicles affect brain development in people with Angelman syndrome.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.